Viewing StudyNCT05813678



Ignite Creation Date: 2024-05-06 @ 6:51 PM
Last Modification Date: 2024-10-26 @ 2:56 PM
Study NCT ID: NCT05813678
Status: RECRUITING
Last Update Posted: 2024-05-13
First Post: 2023-04-03

Brief Title: A Long-term Post-marketing Safety Study of Palynziq in Patients With PKU PALace
Sponsor: BioMarin Pharmaceutical
Organization: BioMarin Pharmaceutical

Conditions & Keywords Data

Conditions:
Name
Phenylketonuria PKU
Keywords:
Name View
Phase 4 View
Observational View
Safety Study View
Pegvaliase View
Palynziq View
PKU View
Phenylketonuria View